Screener
Champions Oncology CSBR Q2 2025 Annual earnings
Reported July 23, 2025 · After market close
Revenue$12.4MMiss by $2.3M
EPS-$0.13Miss by $0.19
Revenue estimate$14.7M
EPS estimate$0.06
Next report
Sep 14, 2026 (In 2 weeks)Revenue estimate$15.0M
EPS estimate-$0.01
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Champions Oncology report Q2 2025 earnings?
- Champions Oncology (CSBR) reported Q2 2025 earnings on July 23, 2025 after market close.
- What were Champions Oncology's Q2 2025 revenue and EPS?
- Champions Oncology reported revenue of $12.4M and eps of $-0.13 for Q2 2025.
- Did Champions Oncology beat estimates in Q2 2025?
- Revenue missed the consensus estimate of $14.7M by $2.3M. EPS missed the consensus estimate of $0.06 by $0.19.
- How did Champions Oncology's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 11.8% from $14.0M a year earlier and eps declined 1200.0% from $-0.01.
- Where can I find Champions Oncology's Q2 2025 SEC filings?
- You can read the 8-K earnings release (0001628280-25-035424) and the 10-K periodic report (0001628280-25-035765) directly on SEC EDGAR. The filing index links above go to sec.gov.
